Onconova Therapeutics, Inc.
NASDAQ:ONTX
0.9953 (USD) • At close April 2, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | 2013 Q4 | 2013 Q3 | 2013 Q2 | 2013 Q1 | 2012 Q4 | 2012 Q3 | 2012 Q2 | 2012 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.056 | 0.056 | 0.057 | 0.057 | 0.056 | 0.056 | 0.057 | 0.057 | 0.056 | 0.056 | 0.057 | 0.057 | 0.056 | 0.057 | 0.066 | 0.056 | 0.052 | 0.03 | 0.063 | 2.022 | 0.068 | 0.059 | 0.12 | 0.485 | 0.564 | 0.143 | 0.11 | 0.324 | 0.21 | 0.173 | 1.651 | 2.248 | 1.474 | 9.597 | 1.622 | 0.123 | 0.114 | 0.114 | 0.114 | 0.125 | 0.447 | 1.93 | 1.116 | 0.591 | 1.116 | 2.969 | 42.803 | 0.22 | 0.198 |
| Cost of Revenue
| 0 | 0.012 | 0.005 | 0.004 | 0.003 | 0.004 | 0.003 | 0.004 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0.056 | 0.044 | 0.052 | 0.053 | 0.053 | 0.052 | 0.054 | 0.053 | 0.056 | 0.056 | 0.057 | 0.057 | 0.056 | 0.057 | 0.066 | 0.056 | 0.052 | 0.03 | 0.063 | 2.022 | 0.068 | 0.059 | 0.12 | 0.485 | 0.564 | 0.143 | 0.11 | 0.324 | 0.21 | 0.173 | 1.651 | 2.248 | 1.474 | 9.597 | 1.622 | 0.123 | 0.114 | 0.114 | 0.114 | 0.125 | 0.447 | 1.93 | 1.116 | 0.591 | 1.116 | 2.969 | 42.803 | 0.22 | 0.198 |
| Gross Profit Ratio
| 1 | 0.786 | 0.912 | 0.93 | 0.946 | 0.929 | 0.947 | 0.93 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 1.912 | 2.434 | 2.46 | 2.456 | 4.08 | 3.773 | 3.593 | 2.038 | 2.002 | 1.745 | 1.763 | 1.852 | 1.937 | 4.534 | 4.193 | 4.801 | 3.37 | 4.047 | 3.521 | 3.895 | 4.075 | 4.292 | 3.985 | 4.07 | 4.577 | 4.478 | 5.141 | 4.614 | 4.886 | 4.694 | 3.991 | 5.564 | 5.822 | 4.603 | 5.282 | 6.512 | 9.498 | 10.387 | 11.886 | 12.904 | 14.248 | 12.086 | 15.293 | 10.047 | 12.756 | 10.576 | 26.962 | 6.776 | 8.448 |
| General & Administrative Expenses
| 3.356 | 2.084 | 2.686 | 2.211 | 2.113 | 2.017 | 2.105 | 2.139 | 2.186 | 2.074 | 2.284 | 2.85 | 2.217 | 1.778 | 2.147 | 2.594 | 1.807 | 1.711 | 1.64 | 1.76 | 3.234 | 1.914 | 1.729 | 2.054 | 1.889 | 1.782 | 1.728 | 1.779 | 2.116 | 1.949 | 1.975 | 2.083 | 3.172 | 1.783 | 2.217 | 2.568 | 2.965 | 3.086 | 3.116 | 3.985 | 4.932 | 4.403 | 5.927 | 3.117 | 0 | 0 | 8.922 | 1.627 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 3.356 | 2.084 | 2.686 | 2.211 | 2.113 | 2.017 | 2.105 | 2.139 | 2.186 | 2.074 | 2.284 | 2.85 | 2.217 | 1.778 | 2.147 | 2.594 | 1.807 | 1.711 | 1.64 | 1.76 | 3.234 | 1.914 | 1.729 | 2.054 | 1.889 | 1.782 | 1.728 | 1.779 | 2.116 | 1.949 | 1.975 | 2.083 | 3.172 | 1.783 | 2.217 | 2.568 | 2.965 | 3.086 | 3.116 | 3.985 | 4.932 | 4.403 | 5.927 | 3.117 | 3.346 | 2.698 | 8.922 | 1.627 | 2.46 |
| Other Expenses
| 0.229 | 0.278 | 0.35 | 0.36 | 0.362 | 0.314 | 0.243 | 0.096 | 0.01 | -0.001 | 0.007 | -0.013 | 0.019 | -0.025 | -0.023 | 0 | 0.096 | 0.008 | 0.027 | 0.04 | 0 | 0.922 | 0.117 | 0.112 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.019 | 0.001 | -0.126 | 0.047 | 0.015 | 0 | 0 | 0.028 | -0.002 | 0 |
| Operating Expenses
| 5.268 | 4.518 | 5.146 | 4.667 | 6.193 | 5.79 | 5.698 | 4.177 | 4.188 | 3.819 | 4.047 | 4.702 | 4.154 | 6.312 | 6.34 | 7.395 | 5.177 | 5.758 | 5.161 | 5.655 | 7.309 | 6.206 | 5.714 | 6.124 | 6.466 | 6.26 | 6.869 | 6.393 | 7.002 | 6.643 | 5.966 | 7.647 | 8.994 | 6.386 | 7.499 | 9.08 | 12.463 | 13.473 | 15.002 | 16.889 | 19.18 | 16.489 | 21.22 | 13.164 | 16.102 | 13.274 | 35.884 | 8.403 | 10.908 |
| Operating Income
| -5.212 | -4.462 | -5.089 | -4.61 | -6.137 | -5.734 | -5.641 | -4.12 | -4.132 | -3.763 | -3.99 | -4.645 | -4.098 | -6.255 | -6.274 | -7.339 | -5.125 | -5.728 | -5.098 | -3.633 | -7.241 | -6.147 | -5.594 | -5.639 | -5.902 | -6.117 | -6.759 | -6.069 | -6.792 | -6.47 | -4.315 | -5.399 | -7.52 | 3.211 | -5.877 | -8.957 | -12.349 | -13.359 | -14.888 | -16.764 | -18.733 | -14.559 | -20.104 | -12.573 | -14.986 | -10.305 | 6.919 | -8.183 | -10.71 |
| Operating Income Ratio
| -93.071 | -79.679 | -89.281 | -80.877 | -109.589 | -102.393 | -98.965 | -72.281 | -73.786 | -67.196 | -70 | -81.491 | -73.179 | -109.737 | -95.061 | -131.054 | -98.558 | -190.933 | -80.921 | -1.797 | -106.485 | -104.186 | -46.617 | -11.627 | -10.465 | -42.776 | -61.445 | -18.731 | -32.343 | -37.399 | -2.614 | -2.402 | -5.102 | 0.335 | -3.623 | -72.821 | -108.325 | -117.184 | -130.596 | -134.112 | -41.908 | -7.544 | -18.014 | -21.274 | -13.428 | -3.471 | 0.162 | -37.195 | -54.091 |
| Total Other Income Expenses Net
| 0.229 | 0.278 | 0.35 | 0.36 | 0.362 | 0.314 | 0.243 | 0.096 | 0.01 | -0.001 | 0.537 | 0.414 | -0.617 | -0.17 | 0.033 | -0.056 | 0.033 | -0.152 | 0.503 | 0.072 | -0.359 | 0.372 | 0.246 | 1.318 | 0.812 | -0.077 | -0.202 | 3.485 | -1.549 | 3.037 | 2.716 | 0.018 | 0.28 | -0.003 | 0.004 | -0.018 | -0.018 | -0.014 | -0.019 | -0.016 | 0.017 | -0.066 | 0.015 | 0.011 | 0.141 | 0.043 | -8.354 | 0.767 | -0.089 |
| Income Before Tax
| -4.983 | -4.184 | -4.739 | -4.25 | -5.775 | -5.42 | -5.398 | -4.024 | -4.122 | -3.764 | -3.453 | -4.231 | -4.715 | -6.425 | -6.241 | -7.395 | -5.092 | -5.737 | -4.595 | -3.561 | -7.6 | -5.775 | -5.348 | -4.321 | -5.09 | -6.194 | -6.961 | -2.584 | -8.341 | -5.433 | -1.599 | -5.381 | -7.24 | 3.208 | -5.873 | -8.975 | -12.367 | -13.373 | -14.907 | -16.78 | -18.716 | -14.625 | -20.089 | -12.562 | -14.845 | -10.262 | -1.435 | -7.416 | -10.799 |
| Income Before Tax Ratio
| -88.982 | -74.714 | -83.14 | -74.561 | -103.125 | -96.786 | -94.702 | -70.596 | -73.607 | -67.214 | -60.579 | -74.228 | -84.196 | -112.719 | -94.561 | -132.054 | -97.923 | -191.233 | -72.937 | -1.761 | -111.765 | -97.881 | -44.567 | -8.909 | -9.025 | -43.315 | -63.282 | -7.975 | -39.719 | -31.405 | -0.969 | -2.394 | -4.912 | 0.334 | -3.621 | -72.967 | -108.482 | -117.307 | -130.763 | -134.24 | -41.87 | -7.578 | -18.001 | -21.255 | -13.302 | -3.456 | -0.034 | -33.709 | -54.54 |
| Income Tax Expense
| 0 | 0.366 | 0 | -0.004 | -0.362 | -0.42 | -0.243 | -0.096 | -0.01 | -0.004 | -0.533 | -0.431 | 0.636 | 0 | -0.06 | 0.056 | 0.063 | 0.024 | -0.476 | 0 | 0.351 | -124,000 | -0.129 | -1.043 | -0.812 | 0.09 | 0.202 | -3.485 | 1.549 | -1.023 | -2.716 | -0.018 | -0.28 | 0.044 | -0.004 | -0.002 | -0.006 | 0.019 | -0.029 | -0.03 | -0.053 | 0.003 | 0.432 | -0.092 | 0 | -0.567 | 8.385 | 0.228 | 0.021 |
| Net Income
| -4.983 | -4.184 | -4.739 | -4.25 | -5.413 | -5 | -5.155 | -3.928 | -4.112 | -3.764 | -3.453 | -4.231 | -4.715 | -6.429 | -6.241 | -7.395 | -5.092 | -5.747 | -4.595 | -3.561 | -7.6 | -5.651 | -5.348 | -4.484 | -5.09 | -6.207 | -6.961 | -2.584 | -8.341 | -5.447 | -1.599 | -5.381 | -7.24 | 3.192 | -5.873 | -8.955 | -12.343 | -13.372 | -14.878 | -16.753 | -18.679 | -14.615 | -20.521 | -12.562 | -14.845 | -10.262 | -1.435 | -7.416 | -10.799 |
| Net Income Ratio
| -88.982 | -74.714 | -83.14 | -74.561 | -96.661 | -89.286 | -90.439 | -68.912 | -73.429 | -67.214 | -60.579 | -74.228 | -84.196 | -112.789 | -94.561 | -132.054 | -97.923 | -191.567 | -72.937 | -1.761 | -111.765 | -95.78 | -44.567 | -9.245 | -9.025 | -43.406 | -63.282 | -7.975 | -39.719 | -31.486 | -0.969 | -2.394 | -4.912 | 0.333 | -3.621 | -72.805 | -108.272 | -117.298 | -130.509 | -134.024 | -41.787 | -7.573 | -18.388 | -21.255 | -13.302 | -3.456 | -0.034 | -33.709 | -54.54 |
| EPS
| -0.24 | -0.2 | -0.23 | -0.2 | -0.26 | -0.24 | -0.25 | -0.19 | -0.2 | -0.24 | -0.22 | -0.27 | -0.32 | -0.53 | -0.52 | -0.65 | -0.48 | -14.04 | -11.22 | -8.98 | -19.35 | -14.94 | -14.14 | -16.52 | -75.65 | -141.77 | -158.99 | -64.61 | -277.16 | -225.37 | -66.16 | -441.86 | -596.38 | 318.06 | -585.19 | -928.17 | -1,279.73 | -1,386.85 | -1,543.36 | -1,740.39 | -1,948.57 | -1,535.35 | -2,982.7 | -1,371.25 | -2,162.73 | -1,495.05 | -209.06 | -1,080.42 | -1,573.28 |
| EPS Diluted
| -0.24 | -0.2 | -0.23 | -0.2 | -0.26 | -0.24 | -0.25 | -0.19 | -0.2 | -0.24 | -0.22 | -0.27 | -0.32 | -0.53 | -0.52 | -0.65 | -0.48 | -14.04 | -11.22 | -8.98 | -19.35 | -14.94 | -14.14 | -16.52 | -75.65 | -141.77 | -158.99 | -64.61 | -277.16 | -225.37 | -66.16 | -441.86 | -596.38 | 318.06 | -585.19 | -928.17 | -1,279.73 | -1,386.85 | -1,543.36 | -1,740.39 | -1,948.57 | -1,535.35 | -2,982.7 | -1,371.25 | -2,162.73 | -1,495.05 | -209.06 | -1,080.42 | -1,573.28 |
| EBITDA
| -5.208 | -4.458 | -5.084 | -4.61 | -6.134 | -5.734 | -5.638 | -4.12 | -4.129 | -3.763 | -4.52 | -5.072 | -3.459 | -6.11 | -6.33 | -7.281 | -5.059 | -5.711 | -5.571 | -3.665 | -6.814 | -5.586 | -5.709 | -6.831 | -6.698 | -6.021 | -6.535 | -9.53 | -5.22 | -7.483 | -7.007 | -5.393 | -7.776 | 3.236 | -5.854 | -8.913 | -12.259 | -13.345 | -14.772 | -16.669 | -18.608 | -14.685 | -20.104 | -12.558 | -14.888 | -10.785 | 7.022 | -8.107 | -10.631 |
| EBITDA Ratio
| -93 | -79.607 | -89.193 | -80.877 | -109.536 | -102.393 | -98.912 | -72.281 | -73.732 | -67.196 | -79.298 | -88.982 | -61.768 | -107.193 | -95.909 | -130.018 | -97.288 | -190.367 | -88.429 | -1.813 | -100.206 | -94.678 | -47.575 | -14.085 | -11.876 | -42.105 | -59.409 | -29.414 | -24.857 | -43.254 | -4.244 | -2.399 | -5.275 | 0.337 | -3.609 | -72.463 | -107.535 | -117.061 | -129.579 | -133.352 | -41.629 | -7.609 | -18.014 | -21.249 | -13.341 | -3.633 | 0.164 | -36.85 | -53.692 |